SD-169 is a potent, ATP-competitive small molecule inhibitor selectively targeting p38alpha and p38beta MAP kinases. It is widely used in research to investigate inflammatory pathways and cellular stress responses, with applications in both in vitro biochemical assays and in vivo disease models.